Big pharma’s blockbuster obesity drug battle is just getting started, and it’s headed for $100 billion

Date:

As Novo Nordisk and Eli Lilly duke it out in the weight-loss drug market with Ozempic, Wegovy and Mounjaro, drug company competitors plan to join the fray…

Share post:

Subscribe

Popular

More like this
Related

NJ Transit, Amtrak service suspended through New York due to power issues

PATH is also reporting "network connection" issues on the...

Trump Media plummets 15% as DJT stock sell-off deepens

Trump Media has been in a slump since a...